Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 15 citing articles:

Cardiovascular therapeutics: A new potential for anxiety treatment?
Kristina Repova, Silvia Aziriova, Kristina Krajcirovicova, et al.
Medicinal Research Reviews (2022) Vol. 42, Iss. 3, pp. 1202-1245
Open Access | Times Cited: 20
Sacubitril/Valsartan and Ivabradine Attenuate Left Ventricular Remodelling and Dysfunction in Spontaneously Hypertensive Rats: Different Interactions with the Renin–Angiotensin–Aldosterone System
Fedor Šimko, Tomáš Baka, Peter Stanko, et al.
Biomedicines (2022) Vol. 10, Iss. 8, pp. 1844-1844
Open Access | Times Cited: 11
Effect of sacubitril/valsartan on the hypertensive heart in continuous light-induced and lactacystin-induced pre-hypertension: Interactions with the renin-angiotensin-aldosterone system
Fedor Šimko, Peter Stanko, Kristina Repova, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 173, pp. 116391-116391
Open Access | Times Cited: 1
Cardiovascular Disease Complicating COVID-19 in the Elderly
Christopher Dayaramani, Joshua De Leon, Allison B. Reiss
Medicina (2021) Vol. 57, Iss. 8, pp. 833-833
Open Access | Times Cited: 12
Nucleic Acid-Based COVID-19 Therapy Targeting Cytokine Storms: Strategies to Quell the Storm
Mai Abdel Haleem Abusalah, Moad Khalifa, Mohammad A. I. Al-Hatamleh, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 3, pp. 386-386
Open Access | Times Cited: 6
The effect of zofenopril on the cardiovascular system of spontaneously hypertensive rats treated with the ACE2 inhibitor MLN-4760
Soňa Čačányiová, Martina Cebová, Fedor Šimko, et al.
Biological Research (2023) Vol. 56, Iss. 1
Open Access | Times Cited: 3
Endothelial dysfunction and COVID‑19 (Review)
Jalil Daher
Biomedical Reports (2021) Vol. 15, Iss. 6
Open Access | Times Cited: 8
Monitoring Non-dipping Heart Rate by Consumer-Grade Wrist-Worn Devices: An Avenue for Cardiovascular Risk Assessment in Hypertension
Tomáš Baka, Fedor Šimko
Frontiers in Cardiovascular Medicine (2021) Vol. 8
Open Access | Times Cited: 6
The counter-regulatory arm of the renin-angiotensin system and COVID-19: insights from Gitelman's and Bartter's syndromes
Lucia Federica Stefanelli, Laura Gobbi, Verdiana Ravarotto, et al.
Journal of Hypertension (2022) Vol. 40, Iss. 4, pp. 648-649
Open Access | Times Cited: 4
Effect of 17β-estradiol on the daily pattern of ACE2, ADAM17, TMPRSS2 and estradiol receptor transcription in the lungs and colon of male rats
Iveta Herichová, Soňa Jendrisková, Paulína Pidíková, et al.
PLoS ONE (2022) Vol. 17, Iss. 6, pp. e0270609-e0270609
Open Access | Times Cited: 4
Commentary: Effect of Angiotensin-Converting-Enzyme Inhibitor and Angiotensin II Receptor Antagonist Treatment on ACE2 Expression and SARS-CoV-2 Replication in Primary Airway Epithelial Cells
Fedor Šimko, Tomáš Baka
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 3
Angiotensin II, RAS Activation, and RAS Blockers in COVID-19: Unambiguous Evidence
Lorenzo A. Calò, Lucia Federica Stefanelli, Federico Nalesso
Kidney & Blood Pressure Research (2022) Vol. 47, Iss. 10, pp. 593-596
Open Access | Times Cited: 2
Renin-angiotensin-aldosterone system inhibitors – a realm of confusion in COVID-19
Angela Mădălina Lazăr
Journal of Ideas in Health (2021) Vol. 4, Iss. Special2, pp. 389-394
Open Access | Times Cited: 2
Ivabradine in the Management of COVID-19-related Cardiovascular Complications: A Perspective
Tomáš Baka, Kristina Repova, Ivan Luptak, et al.
Current Pharmaceutical Design (2022) Vol. 28, Iss. 19, pp. 1581-1588
Closed Access | Times Cited: 1
Morphological aspect of the angiotensin-converting enzyme 2
Ken Yoshimura, Yasuo Okada, Shuji Toya, et al.
Elsevier eBooks (2023), pp. 389-417
Closed Access
Page 1

Scroll to top